| Jul 16 |
Are You Looking for a Top Momentum Pick? Why Nurix Therapeutics, Inc. (NRIX) is a Great Choice
|
| Jul 11 |
Nurix Therapeutics, Inc. (NRIX) Reports Q2 Loss, Lags Revenue Estimates
|
| Jul 11 |
Nurix Therapeutics GAAP EPS of -$0.71 misses by $0.08, revenue of $12.09M misses by $9.69M
|
| Jul 11 |
Nurix Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
|
| Jul 8 |
Nurix Therapeutics to Participate in the UBS Virtual Targeted Protein Degradation (TPD) Day
|
| Jul 7 |
Earnings week ahead: PepsiCo, Delta Air Lines, JPMorgan, Citigroup and more
|
| Jul 2 |
Nurix Therapeutics, Inc. (NASDAQ:NRIX) is a favorite amongst institutional investors who own 66%
|
| Jun 25 |
Beyond Air, Inc. Reports Q4 Loss, Misses Revenue Estimates
|
| Jun 24 |
Beyond Air, Inc. (XAIR) Reports Q4 Loss, Misses Revenue Estimates
|
| Jun 20 |
Insider Sale: CFO Houte Van Sells 20,000 Shares of Nurix Therapeutics Inc (NRIX)
|
